Japanese drugmaker Eisai has announced that the administration of the anticancer agent EZH2 inhibitor Tazverik tablets 200mg ...

Japanese drugmaker Shionogi says it has launched Zurvae capsules 30mg (zuranolone) for the treatment of major depressive disorder (MDD).

USA-based immunotherapy specialist SAB Biotherapeutics has announced the closing of an underwritten public offering, ...

UK pharma major GSK has announced that the US Food and Drug Administration (FDA) has approved Lynavoy (linerixibat) for the treatment of cholestatic pruritus in adult patients with PBC.

US biotech Azitra (NYSE American: AZTR) has secured financing of up to $31.4 million, combining an initial $10.5 million ...

A group of Senate Democrats has set out an expansive healthcare reform agenda, targeting rising insurance costs and insurer profits while positioning the effort as a response to recent Republican-led ...

Montreal, Canada-based Congruence Therapeutics, a clinical-stage, computationally-driven biotechnology company building a unique pipeline of pharmacological correctors for diseases of protein ...

Swiss pharma giant Novartis today announced that it has entered into an agreement with Synnovation Therapeutics to acquire ...

Fauna Bio, a specialist in the use of extreme mammal biology and comparative genomics, has announced the designation of a target under its strategic obesity discovery collaboration with Eli Lilly that ...

The UK’s National Institute for Health and Care Excellence (NICE) has published a successful outcome for Eli Lilly’s appeal against final draft guidance which does not recommend National Health ...

US-German biotech Galimedix Therapeutics has unveiled preclinical data for a next-generation oral Alzheimer’s candidate, ...

Indian drugmaker Glenmark Pharmaceuticals has announced the introduction of two generic products to the US market.